Evidence map›Paper›PMID 40759705›Full record

ArticleScientific reports2025

Immune cell subsets in autoimmune polyendocrine syndrome type I.

Shahinul Islam, Bergithe E Oftedal, Miriam Gjerdevik, Lars Breivik, Ellen C Røyrvik, Kari Lima, Anders P Jørgensen, Ifunanya Nwakwuo, Jørn Skavland, Eystein S Husebye and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shahinul IslamDepartment of Medicine, Haukeland University hospital, Bergen, Norway.
Bergithe E OftedalDepartment of Medicine, Haukeland University hospital, Bergen, Norway.
Miriam GjerdevikDepartment of Computer science, Electrical engineering and Mathematical sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Lars BreivikDepartment of Medicine, Haukeland University hospital, Bergen, Norway.
Ellen C RøyrvikDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Kari LimaDepartment of Paediatric Medicine, Oslo University Hospital, Oslo, Norway.
Anders P JørgensenDepartment of Endocrinology, Oslo University Hospital, Oslo, Norway.
Ifunanya NwakwuoDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Jørn SkavlandDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Eystein S HusebyeDepartment of Medicine, Haukeland University hospital, Bergen, Norway.
Anette S B WolffDepartment of Medicine, Haukeland University hospital, Bergen, Norway. Anette.susanne.boe.wolff@helse-bergen.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune Polyendocrine Syndrome Type 1 (APS-I) results from mutations in the Autoimmune Regulator (AIRE) gene and serves as a valuable model to understand autoimmunity and immune deficiency. Various studies have produced differing results on how AIRE dysfunction affects the balance of immune cell subsets in blood in humans. We conducted high-resolution whole blood immune cell subset analysis using a 36-panel mass cytometry assay in Norwegian APS-I patients (N = 18) and compared with age and sex-matched healthy subjects (N = 19). Additionally, we provide a comprehensive summary of findings from 28 other studies examining blood immune subset distributions in APS-I patients. Norwegian APS-I patients had significantly reduced numbers of B cells, which was driven by lower levels of the naïve and transitional B cell compartments. We further observed trends indicating reduced frequencies of NK cells, as well as deviations in CD16-expressing cells in several subsets in APS-I patients. Contrary to previous reports, our study did not find differences in regulatory T cell levels between APS-I patients and healthy controls. Several studies in our summary consistently reported lower frequencies of resting naïve B cells in APS-I patients and higher proportions of activated memory B cells in APS-I patients. The composition of other immune cell subsets was more diverse between studies, probably reflecting contributions by other factors like medications, ethnicity, disease complexity, insufficient sample sizes, time of sampling, ages, unique immune profiles and health conditions of the patients and controls. Future research should prioritize investigating antigen-specific responses in blood and tissues to further illuminate this complex area.

Indexed as

Polyendocrinopathies, AutoimmuneAdultAIRE ProteinB-LymphocytesCase-Control StudiesFemaleHumansKiller Cells, NaturalMaleMiddle AgedT-Lymphocytes, RegulatoryYoung AdultAIRE ProteinAPS-IAutoimmune polyendocrine syndrome type IHigh dimensionalImmune phenotypingImmune subsetsMass cytometryProteomic

Identifiers

PMID40759705
PMCPMC12322070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.